2nd-trimester maternal serum human chorionic gonadotropin and α-fetoprotein levels in male and female fetuses with Down syndrome

Fetal Diagnosis and Therapy

Volumn 20, Issue 3, 2005, Pages 235-238

  Lehavi, Ofer ^a   Aizenstein, Orna ^b   Evans, Mark I ^d   Yaron, Yuval ^b,c  

^a LIS MATERNITY HOSPITAL   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Fetoprotein; Down syndrome; Fetal gender; Human chorionic gonadotropin; Maternal serum

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; BLOOD ANALYSIS; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; FEMALE; FETUS; FETUS MONITORING; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; SEX DIFFERENCE; STATISTICAL ANALYSIS; TRISOMY 21;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SEX FACTORS;

EID: 17844377068     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083911     Document Type: Article

References (18)

1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE: An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-894.
2. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA: Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-887.
3. O'Brien JE, Dvorin E, Drugan A, Johnson MP, Yaron Y, Evans MI: Race-ethnicity-specific variation in multiple-marker biochemical screening: Alpha-fetoprotein, hCG, and estriol. Obstet Gynecol 1997;89:355-358.
4. Leporrier N, Herrou M, Leymarie P: Shift of the fetal sex ratio in hCG selected pregnancies at risk for Down syndrome. Prenat Diagn 1992;12:703-704.
5. Lockwood CJ, Lynch L, Ghidini A, Lapinski R, Berkowitz G, Thayer B, Miller WA: The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters. Am J Obstet Gynecol 1993;169:1190-1197.
6. Santolaya-Forgas J, Meyer WJ, Burton BK, Scommegna A: Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG). J Matern Fetal Med 1997;6:111-114.
7. Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, Johnson MP, Evans MI: Fetal gender impact on multiple-marker screening results. Am J Med Genet 1998;76:369-371.
8. Ghidini A, Spong CY, Grier RE, Walker CN, Pezzullo JC: Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses? Prenat Diagn 1998;18:123-126.
9. Spong CY, Ghidini A, Stanley-Christian H, Meek JM, Seydel FD, Pezzullo JC: Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses. Prenat Diagn 1999;19:337-339.
10. Steier JA, Myking OL, Bergsjö PB: Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies. Acta Obstet Gynecol Scand 1999;78:367-371.
11. Spencer K: The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG. Prenat Diagn 2000;20:648-651.
12. Calvas P, Bourrouillou G, Smilovici W, Colombies P: Maternal serum alpha-fetoprotein and fetal sex. Prenat Diagn 1990;10:134-136.
13. Petrikovsky B: Maternal serum alpha fetoprotein concentration and fetal sex. Prenat Diagn 1989;9:449-450.
14. Sowers SG, Reish RL, Burton BK: Fetal sex-related differences in maternal serum alpha-fetoprotein during the second trimester of pregnancy. Am J Obstet Gynecol 1983;146:786-789.
15. Aitken DA, McCaw G, Crossley JA, Berry E, Connor JM, Spencer K, Macri JN: First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat Diagn 1993;13:681-689.
16. Yaron Y, Lehavi O, Orr-Urtreger A, Gull I, Lessing JB, Amit A, Ben-Yosef D: Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod 2002;17:485-489.
17. de Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM: Co-variables in first trimester maternal serum screening Prenat Diagn 2000;20:186-189.
18. Yaron Y, Wolman I, Kupfermine MJ, Ochshorn Y, Many A, Orr-Urtreger A: Fetal gender impact on first trimester markers and its effect on Down syndrome screening. Prenat Diagn 2001;21:1027-1030.